you look at the timele of the merger with biomet.sy to understand why it could have a lot more upside. it goes back nearly two and a half years ago to april 2014 when the old zimmer holding the announced it would be acquiring b biomet. they were expanding their product line pretty dramatically, creating many more cross-selling opportunities and giving the company more leverage when it comes to negotiating prices with the hospitals. in fact, zimmer's own stock rallied 11% the day of the announcement. you know it's going to get a good deal. that's why from april 2014 to february 2015, zimmer's shares roared more than 30% higher, peaking at roughly 121. then the company started running into speed bumps. at this point, they briefed that the biomed deal would close in the first part of 2015. however, it took longer than expected to get approval from the ftc, and the merger didn't close until june of 2015. that meant those that people were excited about got ended up pushing back from last year to this year. they would have to push back the